COMMUNITY HEALTH SYSTEMS INC (CYH) Stock Fundamental Analysis
NYSE:CYH - New York Stock Exchange, Inc. - US2036681086 - Common Stock - Currency: USD
Overall CYH gets a fundamental rating of 3 out of 10. We evaluated CYH against 104 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CYH while its profitability can be described as average. CYH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
CYH had negative earnings in the past year.
In the past year CYH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CYH reported negative net income in multiple years.
Of the past 5 years CYH 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CYH (-1.41%) is comparable to the rest of the industry.
CYH has a better Return On Invested Capital (6.13%) than 65.38% of its industry peers.
CYH had an Average Return On Invested Capital over the past 3 years of 5.27%. This is below the industry average of 9.61%.
The 3 year average ROIC (5.27%) for CYH is below the current ROIC(6.13%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.41% | ||
| ROE | N/A | ||
| ROIC | 6.13% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
1.3 Margins
CYH's Operating Margin of 6.96% is fine compared to the rest of the industry. CYH outperforms 70.19% of its industry peers.
In the last couple of years the Operating Margin of CYH has remained more or less at the same level.
CYH has a better Gross Margin (84.71%) than 97.12% of its industry peers.
CYH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.96% | ||
| PM (TTM) | N/A | ||
| GM | 84.71% |
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CYH is creating some value.
CYH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CYH has been increased compared to 5 years ago.
CYH has a worse debt/assets ratio than last year.
2.2 Solvency
CYH has an Altman-Z score of 0.88. This is a bad value and indicates that CYH is not financially healthy and even has some risk of bankruptcy.
CYH has a worse Altman-Z score (0.88) than 72.12% of its industry peers.
CYH has a debt to FCF ratio of 79.88. This is a negative value and a sign of low solvency as CYH would need 79.88 years to pay back of all of its debts.
CYH's Debt to FCF ratio of 79.88 is on the low side compared to the rest of the industry. CYH is outperformed by 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 79.88 | ||
| Altman-Z | 0.88 |
ROIC/WACC1.13
WACC5.44%
2.3 Liquidity
CYH has a Current Ratio of 1.59. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
CYH has a Current ratio (1.59) which is in line with its industry peers.
CYH has a Quick Ratio of 1.45. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
CYH has a Quick ratio (1.45) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
CYH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.81%, which is quite impressive.
Looking at the last year, CYH shows a small growth in Revenue. The Revenue has grown by 0.79% in the last year.
CYH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.89% yearly.
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.59%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%-0.22%
3.2 Future
Based on estimates for the next years, CYH will show a very strong growth in Earnings Per Share. The EPS will grow by 26.56% on average per year.
Based on estimates for the next years, CYH will show a small growth in Revenue. The Revenue will grow by 1.87% on average per year.
EPS Next Y72.94%
EPS Next 2Y38.97%
EPS Next 3Y26.56%
EPS Next 5YN/A
Revenue Next Year-0.68%
Revenue Next 2Y0.77%
Revenue Next 3Y1.87%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
CYH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CYH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
77.88% of the companies in the same industry are more expensive than CYH, based on the Enterprise Value to EBITDA ratio.
CYH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CYH is cheaper than 99.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.73 | ||
| EV/EBITDA | 8.07 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CYH's earnings are expected to grow with 26.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.97%
EPS Next 3Y26.56%
5. Dividend
5.1 Amount
No dividends for CYH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.65
-0.08 (-2.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners81.32%
Inst Owner Change2.61%
Ins Owners7.63%
Ins Owner Change4.74%
Market Cap371.32M
Analysts54.12
Price Target3.63 (36.98%)
Short Float %10.87%
Short Ratio4.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.59%
Min EPS beat(2)52.57%
Max EPS beat(2)62.61%
EPS beat(4)2
Avg EPS beat(4)-138.61%
Min EPS beat(4)-607.99%
Max EPS beat(4)62.61%
EPS beat(8)3
Avg EPS beat(8)-184.07%
EPS beat(12)5
Avg EPS beat(12)-182.87%
EPS beat(16)8
Avg EPS beat(16)-462.39%
Revenue beat(2)2
Avg Revenue beat(2)1.86%
Min Revenue beat(2)0.99%
Max Revenue beat(2)2.72%
Revenue beat(4)3
Avg Revenue beat(4)1.4%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)2.72%
Revenue beat(8)5
Avg Revenue beat(8)0.82%
Revenue beat(12)6
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.08%
PT rev (1m)-15.08%
PT rev (3m)-11.09%
EPS NQ rev (1m)-5.75%
EPS NQ rev (3m)-25.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.52%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | 2.73 | ||
| P/OCF | 0.76 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.07 |
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.97
FCFY36.63%
OCF(TTM)3.5
OCFY132.23%
SpS90.26
BVpS-11.64
TBVpS-37.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.41% | ||
| ROE | N/A | ||
| ROCE | 7.76% | ||
| ROIC | 6.13% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 9.54% | ||
| OM | 6.96% | ||
| PM (TTM) | N/A | ||
| GM | 84.71% | ||
| FCFM | 1.08% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
ROICexc(3y)5.3%
ROICexc(5y)5.61%
ROICexgc(3y)7.93%
ROICexgc(5y)8.5%
ROCE(3y)6.68%
ROCE(5y)6.87%
ROICexcg growth 3Y-11.89%
ROICexcg growth 5Y0.9%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y0.93%
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
F-Score7
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 79.88 | ||
| Debt/EBITDA | 8.11 | ||
| Cap/Depr | 77.85% | ||
| Cap/Sales | 2.81% | ||
| Interest Coverage | 1.12 | ||
| Cash Conversion | 36.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 0.88 |
F-Score7
WACC5.44%
ROIC/WACC1.13
Cap/Depr(3y)81.42%
Cap/Depr(5y)81.99%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.59%
EPS Next Y72.94%
EPS Next 2Y38.97%
EPS Next 3Y26.56%
EPS Next 5YN/A
Revenue 1Y (TTM)0.79%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%-0.22%
Revenue Next Year-0.68%
Revenue Next 2Y0.77%
Revenue Next 3Y1.87%
Revenue Next 5YN/A
EBIT growth 1Y-6.78%
EBIT growth 3Y-12.97%
EBIT growth 5Y-1.39%
EBIT Next Year52.34%
EBIT Next 3Y17.2%
EBIT Next 5YN/A
FCF growth 1Y163.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.17%
OCF growth 3YN/A
OCF growth 5Y4.51%